These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6097166)

  • 21. Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.
    Pollock AA; Tee PE; Patel IH; Spicehandler J; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1982 Nov; 22(5):816-23. PubMed ID: 6295268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of probenecid on the pharmacokinetics of cefotaxime in sheep.
    Guerrini VH; Filippich LJ; English PB; Cao GR; Bourne DW
    J Vet Pharmacol Ther; 1985 Mar; 8(1):38-46. PubMed ID: 3989899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study of ceftizoxime, a new cephalosporin. Single-dose study.
    Nakashima N; Suzuki K; Hashimoto H; Nishijima K
    J Clin Pharmacol; 1981 Oct; 21(10):388-95. PubMed ID: 6273456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental and clinical studies of cefotiam in thoracic surgery].
    Matsuura Y; Tamura M; Yamashina H; Higo M; Fujii T
    Jpn J Antibiot; 1983 Mar; 36(3):537-46. PubMed ID: 6308294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Noncompartment (model-independent) pharmacokinetic analysis. 1. The method of statistical moments in evaluating the pharmacokinetic characteristics of cefotiam following its intravenous administration].
    Terzinvanov D
    Vutr Boles; 1986; 25(2):89-93. PubMed ID: 3459308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ceforanide.
    Ripa S; La Rosa F; Ghezzi A; Prenna M; Pfeffer M
    Antimicrob Agents Chemother; 1982 Feb; 21(2):323-6. PubMed ID: 7073268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The studies on distributions of cefsulodin and cefotiam to human aqueous humor and cornea].
    Momose A; Kasahara A; Fugono T; Mizuta E
    Jpn J Antibiot; 1982 Dec; 35(12):2879-93. PubMed ID: 6304364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Concentration of cefotiam in the exudate of pericardium].
    Tanaka S; Takagi K; Kusama Y; Ogata T
    Jpn J Antibiot; 1982 May; 35(5):1131-5. PubMed ID: 6290696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absolute bioavailability of ceftriaxone after intramuscular administration to healthy volunteers.
    Delsignore R; Baroni CM; Crotti G; Mineo F; Butturini U; Ascalone V; Cisternino M
    Chemotherapy; 1983; 29(3):157-62. PubMed ID: 6307601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cefotiam in the exudate from wounds of patients with breast cancer operated upon for radical mastectomy.
    Mizuta E; Kaneko Y; Nishindai H; Yoshimoto M; Nakanishi Y; Hashimoto I; Sawada Y; Nakamura T; Mikami J
    Jpn J Antibiot; 1986 Jan; 39(1):109-15. PubMed ID: 3457961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary elimination of cefotiam, an experimental and clinical study.
    Brogard JM; Arnaud JP; Blickle JF; Levy P; Dorner M; Lautier F
    Chemotherapy; 1986; 32(3):222-35. PubMed ID: 3458565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cefotiam preparations].
    Jpn J Antibiot; 1982 Apr; 35(4):1080-3. PubMed ID: 6285026
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacokinetics and clinical evaluation of cefotiam in pediatric surgery].
    Yura J; Tsuruga N; Hashimoto T; Kamiya Y; Hayashi S; Murata Y
    Jpn J Antibiot; 1986 Sep; 39(9):2483-7. PubMed ID: 3467089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
    Pangon B; Joly V; Vallois JM; Abel L; Buré A; Brion N; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1987 Apr; 31(4):518-22. PubMed ID: 3300530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cefpirome (HR 810), a new cephalosporin derivative administered intramuscularly and intravenously to healthy volunteers.
    Maass L; Malerczyk V; Verho M
    Infection; 1987; 15(3):207-10. PubMed ID: 3610329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cefotaxime in the dog.
    Guerrini VH; English PB; Filippich LJ; Schneider J; Bourne DW
    Vet Rec; 1986 Jul; 119(4):81-3. PubMed ID: 3750783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents.
    Patel IH; Weinfeld RE; Konikoff J; Parsonnet M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):957-62. PubMed ID: 6287931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cefotaxime in sheep.
    Guerrini VH; Filippich L; English PB; Bourne DW
    Am J Vet Res; 1983 Aug; 44(8):1488-91. PubMed ID: 6312852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.